Abacus FCF Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Buy |
16,746
+287
| +2% | +$90.1K | 0.74% | 48 |
|
|
2025
Q1 | $5.01M | Buy |
16,459
+6,931
| +73% | +$2.11M | 0.79% | 41 |
|
|
2024
Q4 | $3.17M | Buy |
9,528
+2,976
| +45% | +$989K | 0.42% | 73 |
|
|
2024
Q3 | $2.19M | Sell |
6,552
-3,221
| -33% | -$1.08M | 0.51% | 77 |
|
|
2024
Q2 | $4.03M | Buy |
9,773
+4
| +0% | +$1.65K | 1% | 28 |
|
|
2024
Q1 | $3.95M | Sell |
9,769
-36
| -0.4% | -$14.5K | 0.99% | 28 |
|
|
2023
Q4 | $3.01M | Buy |
9,805
+4,356
| +80% | +$1.34M | 0.87% | 29 |
|
|
2023
Q3 | $1.32M | Sell |
5,449
-150
| -3% | -$36.3K | 0.7% | 45 |
|
|
2023
Q2 | $1.34M | Sell |
5,599
-36
| -0.6% | -$8.65K | 0.68% | 50 |
|
|
2023
Q1 | $1.06M | Buy |
5,635
+720
| +15% | +$135K | 0.57% | 68 |
|
|
2022
Q4 | $1.04M | Sell |
4,915
-108
| -2% | -$22.9K | 0.68% | 49 |
|
|
2022
Q3 | $789K | Buy |
+5,023
| New | +$789K | 0.54% | 80 |
|